Stockreport

Altamira Therapeutics receives Nasdaq non-compliance letter [Seeking Alpha]

Altamira Therapeutics Ltd. - Common Shares  (CYTO) 
PDF The letter stated that the company is not eligible for any cure period due to the fact that it effectuated one or more reverse stock splits over the prior two-year peri [Read more]